Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Lymphocytic Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00105001
What this trial is testing

Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Myelodysplastic/Myeloproliferative Neoplasm, UnclassifiablePreviously Treated Myelodysplastic SyndromeRefractory Chronic Lymphocytic Leukemia+113 more
Fred Hutchinson Cancer Center 210
Testing effectiveness (Phase 2)Ended earlyNCT00524667
What this trial is testing

HDAC Inhibitor Valproic Acid as an Effective Therapy for Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
CancerCare Manitoba 6
Testing effectiveness (Phase 2)Study completedNCT02396134
What this trial is testing

Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+11 more
City of Hope Medical Center 61
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06979076
What this trial is testing

A Phase Ib Study of the Selective PKC-β Inhibitor MS-553 in Patients With Refractory or Relapsed CLL/SLL

Who this might be right for
CLL (Chronic Lymphocytic Leukemia)SLL (Small Lymphocytic Lymphoma)
MingSight Pharmaceuticals, Inc 12
Not applicableStudy completedNCT04172467
What this trial is testing

Quality Assurance of Secondary Immunodeficiencies (SID) in CLL/MM Patients

Who this might be right for
Secondary Immunodeficiencies (SID)
AIO-Studien-gGmbH 1,086
Not applicableUnknownNCT05899543
What this trial is testing

Determining Clinical Study Experiences of Chronic Lymphocytic Leukemia Patients

Who this might be right for
Chronic Lymphocytic Leukemia
Power Life Sciences Inc. 500
Testing effectiveness (Phase 2)UnknownNCT00003885
What this trial is testing

Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or Myeloma

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Our Lady of Mercy Medical Center 60
Early research (Phase 1)Study completedNCT00002625
What this trial is testing

Topotecan and Radiation Therapy in Treating Patients With Solid Tumors or Lymphoma

Who this might be right for
Esophageal CancerLung CancerLymphoma
National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)Study completedNCT00764517
What this trial is testing

Vorinostat, Cladribine, and Rituximab in Treating Patients With Mantle Cell Lymphoma, Relapsed Chronic Lymphocytic Leukemia, or Relapsed B Cell Non-Hodgkin's Lymphoma

Who this might be right for
Recurrent B-Cell Non-Hodgkin LymphomaRecurrent Chronic Lymphocytic LeukemiaRecurrent Indolent Adult Non-Hodgkin Lymphoma+1 more
OHSU Knight Cancer Institute 57
Testing effectiveness (Phase 2)Looking for participantsNCT07671378
What this trial is testing

MRD-Guided Zanubrutinib Plus Sonrotoclax in Treatment-Naïve, High-Risk CLL/SLL Patients

Who this might be right for
CLL (Chronic Lymphocytic Leukemia)
The First Affiliated Hospital with Nanjing Medical University 24
Early research (Phase 1)Ended earlyNCT06343376
What this trial is testing

Genetically Engineered Cells (EGFRt/19-28z/IL-12 CAR T Cells) for the Treatment of Relapsed or Refractory CD19+ Hematologic Malignancies

Who this might be right for
Recurrent Chronic Lymphocytic LeukemiaRecurrent Diffuse Large B-Cell LymphomaRecurrent Follicular Lymphoma+11 more
Roswell Park Cancer Institute 1
Not applicableUnknownNCT02828774
What this trial is testing

Peptide-drug-conjugates for Personalized, Targeted Therapy of Chronic Lymphocytic Leukemia

Who this might be right for
CLL
Assuta Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT00267059
What this trial is testing

Lenalidomide (Revlimid) in Chronic Lymphocytic Leukemia (CLL)

Who this might be right for
Chronic Lymphocytic LeukemiaLeukemia
M.D. Anderson Cancer Center 45
Early research (Phase 1)Study completedNCT01353625
What this trial is testing

Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.

Who this might be right for
Glioblastoma MultiformeSquamous Cell Carcinoma of Head and NeckProstate Cancer+3 more
Celgene 118
Testing effectiveness (Phase 2)Study completedNCT02013817
What this trial is testing

CHAIROS Study A Study of MabThera/Rituxan (Rituximab) Maintenance Therapy in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Naive to Chemotherapy

Who this might be right for
Lymphocytic Leukemia, Chronic
Hoffmann-La Roche 43
Early research (Phase 1)Ended earlyNCT02137889
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VAY736 in Relapsed or Refractory CLL Patients

Who this might be right for
Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Novartis Pharmaceuticals 3
Testing effectiveness (Phase 2)Study completedNCT00644189
What this trial is testing

Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphoma

Who this might be right for
Follicular LymphomaMarginal Zone LymphomaMantle Cell Lymphoma+7 more
Massachusetts General Hospital 50
Testing effectiveness (Phase 2)Study completedNCT03788291
What this trial is testing

Acalabrutinib and High Frequency Low Dose Subcutaneous Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)
University of Rochester 39
Not applicableStudy completedNCT01081015
What this trial is testing

Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry

Who this might be right for
Chronic Lymphocytic Leukemia
Celgene 1,494
Early research (Phase 1)Study completedNCT01841489
What this trial is testing

Novel GS-9973 Tablet Formulations to Evaluate the Effect of Acid Reducing Agents, Relative Bioavailability, and Food Effect on GS-9973 Pharmacokinetics

Who this might be right for
Chronic Lymphocytic Leukemia
Gilead Sciences 56
Next Page